scholarly journals Parathyroid hormone reflects adiposity and cardiometabolic indices but not bone density in normal men

2016 ◽  
Vol 5 ◽  
Author(s):  
Emma O Billington ◽  
Greg D Gamble ◽  
Ian R Reid
Keyword(s):  
Parathyroid Hormone ◽  
Bone Density ◽  
Normal Men

The Circadian Rhythm of Intact Parathyroid Hormone-(1–84): Temporal Correlation with Prolactin Secretion in Normal Men

1990 ◽  
Vol 71 (6) ◽  
pp. 1556-1560 ◽  
Author(s):  
F. C. LOGUE ◽  
W. D. FRASER ◽  
D. ST. J. O'REILLY ◽  
D. A. CAMERON ◽  
A. J. KELLY ◽  
...  
Keyword(s):  
Circadian Rhythm ◽  
Parathyroid Hormone ◽  
Temporal Correlation ◽  
Prolactin Secretion ◽  
Intact Parathyroid Hormone ◽  
Normal Men

scholarly journals No association between vitamin D deficiency and parathyroid hormone, bone density and bone turnover in a large cohort of HIV-infected men on tenofovir

2014 ◽  
Vol 17 ◽  
pp. 19568 ◽  
Author(s):  
Amanda Samarawickrama ◽  
Sophie Jose ◽  
Caroline Sabin ◽  
Karen Walker-Bone ◽  
Martin Fisher ◽  
...  
Keyword(s):  
Vitamin D ◽  
Parathyroid Hormone ◽  
Bone Density ◽  
Bone Turnover ◽  
Vitamin D Deficiency ◽  
Large Cohort

scholarly journals The use of PTH in the treatment of osteoporosis

2010 ◽  
Vol 54 (2) ◽  
pp. 213-219 ◽  
Author(s):  
Victória Z. Cochenski Borba ◽  
Nádila Cecyn Pietszkowski Mañas
Keyword(s):  
Parathyroid Hormone ◽  
Bone Density ◽  
Adverse Effects ◽  
Combination Therapy ◽  
Biochemical Markers ◽  
Osteoporosis Treatment ◽  
Antiresorptive Therapy ◽  
Treatment Of Osteoporosis ◽  
Antiresorptive Agents ◽  
Anabolic Treatment

Anabolic drugs have recently widened therapeutic options in osteoporosis treatment, as they influence processes associated with bone formation to a greater extent and earlier than bone reabsortion. They positively affect a number of skeletal properties besides bone density, as intermittent administration of parathyroid hormone (PTH) results in an increase in the number and activity of osteoblasts leading to an increase in bone mass and improvement in skeletal architecture at both the trabecular and cortical bone. Human recombinant parathyroid hormone (hrPTH 1-84) and human recombinant PTH peptide 1-34 (teriparatide) belong to this group. The objective of this paper is to review PTH actions, benefits and adverse effects, action on biochemical markers, combination therapy with antiresorptive agents, impact of antiresorptive therapy prior to anabolic treatment, sequential treatment, and effect on glucocorticoid-induced osteoporosis.

THE CIRCADIAN RHYTHM OF INTACT PARATHYROID HORMONE (1-84) AND NEPHROGENOUS CYCLIC ADENOSINE MONOPHOSPHATE IN NORMAL MEN

1989 ◽  
Vol 121 (1) ◽  
pp. R1-R3 ◽  
Author(s):  
F.C. Logue ◽  
W.D. Fraser ◽  
D.St.J. O'Reilly ◽  
G.H. Beastall
Keyword(s):  
Circadian Rhythm ◽  
Parathyroid Hormone ◽  
Cyclic Adenosine Monophosphate ◽  
Adenosine Monophosphate ◽  
Significant Rise ◽  
Optimal Time ◽  
Normal Male ◽  
Intact Parathyroid Hormone ◽  
Normal Men ◽  
Nocturnal Rise

ABSTRACT A pronounced circadian rhythm has been demonstrated for intact parathyroid hormone (1-84) in the serum of normal male adults. The broad nocturnal rise of parathyroid hormone (1-84) secretion appears to be of physiological significance, for it is accompanied by a significant rise in nephrogenous cyclic adenosine monophosphate. The rate of return of parathyroid hormone (1-84) to baseline concentrations varies between individuals, an observation which has implications for the optimal time of sampling for the investigation of possible mild hyperparathyroidism.

Sign in / Sign up

Export Citation Format

Share Document